Articles

What is the difference between primary hyperparathyroidism and secondary hyperparathyroidism?

What is the difference between primary hyperparathyroidism and secondary hyperparathyroidism?

Parathyroid glands can go crazy all on their own (called primary hyperparathyroidism) or when some other disease forces them to go crazy (called secondary hyperparathyroidism). Secondary hyperparathyroidism is a disease of the parathyroid glands that was caused by some other disease.

What is the difference between sensipar and cinacalcet?

Sensipar is a drug manufactured by Amgen. Sensipar is the trade name, the generic name for this drug is “Cinacalcet”. Sensipar comes as a small pill in three strengths (30mg, 60mg, and 90mg). This drug was designed for the treatment of SECONDARY hyperparathyroidism.

What is the difference between primary and secondary hypoparathyroidism?

Primary hypoparathyroidism, the subject of this article, is a syndrome resulting from iatrogenic causes or one of many rare diseases. Secondary hypoparathyroidism is a physiologic state in which PTH levels are low in response to a primary process that causes hypercalcemia.

What is the difference between secondary and tertiary hyperparathyroidism?

In secondary hyperparathyroidisrn, the serum calcium is normal and the PTH level is elevated. Tertiary hyperparathyroidism is characterized by excessive secretion of PTH after longstanding secondary hyperparathyroidism. in which hypercalcemia has ensued.

Is secondary hyperparathyroidism chronic?

When calcium levels are low, parathyroid hormone is produced to try and raise blood calcium levels to normal. Long-term high parathyroid hormone secretion due to chronic hypocalcaemia is called secondary hyperparathyroidism.

When is the best time to take Sensipar?

Take Sensipar® with food or shortly after a meal. Take Sensipar® at least 12 hours before your PTH blood test. Regular blood testing is important in monitoring safety and efficacy.

What are the three types of hyperparathyroidism?

There are three types of hyperparathyroidism: primary, secondary, and tertiary.

What are the symptoms of secondary hyperparathyroidism?

Symptoms of SHPT include:

  • Weak or broken bones (osteoporosis)
  • Bone and joint pain.
  • Kidney stones.
  • Urinating (peeing) more often than normal.
  • Belly pain.
  • Feeling weak or tired easily.
  • Feeling sick to your stomach or throwing up.
  • Feeling less hungry than usual (loss of appetite)

What are the 3 types of hyperparathyroidism?

Can hyperparathyroidism affect your kidneys?

Hyperparathyroidism (HPT) is a condition that causes one or more parathyroid glands to produce an excess amount of parathyroid hormone (PTH). This disrupts the blood calcium level in the body and can lead to kidney failure.

When was Sensipar approved for primary hyperparathyroidism?

Let us make this simple…if you have a parathyroid problem, and you are not on kidney dialysis, then you have PRIMARY hyperparathyroidism. Sensipar was approved by the FDA for the treatment of SECONDARY hyperparathyroidism in March 2004.

Is there a difference between primary and secondary hyperparathyroidism?

We cannot confuse primary and secondary hyperparathyroidism. Let us make this simple…if you have a parathyroid problem, and you are not on kidney dialysis, then you have PRIMARY hyperparathyroidism. Sensipar was approved by the FDA for the treatment of SECONDARY hyperparathyroidism in March 2004.

Can a diabetic take Sensipar with kidney failure?

Sensipar (cinacalcet) should not be used for high blood calcium caused by primary hyperparathyroidism. Secondary hyperparathyroidism is a disease that occurs in patients with kidney failure that are on dialysis. These patients do NOT get parathyroid tumors like patients with PRIMARY hyperparathyroidism.

What do you need to know about Sensipar?

What is Sensipar? Sensipar (cinacalcet) decreases levels of parathyroid hormone (PTH), calcium, and phosphorous in the body. Sensipar is used to treat hyperparathyroidism (overactive functioning of the parathyroid glands) in people who are on long-term dialysis for kidney disease.